Literature DB >> 24446210

Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.

Ruth Rubio1, Ander Abarrategi, Javier Garcia-Castro, Lucia Martinez-Cruzado, Carlos Suarez, Juan Tornin, Laura Santos, Aurora Astudillo, Isabel Colmenero, Francisca Mulero, Michael Rosu-Myles, Pablo Menendez, Rene Rodriguez.   

Abstract

The cellular microenvironment plays a relevant role in cancer development. We have reported that mesenchymal stromal/stem cells (MSCs) deficient for p53 alone or together with RB (p53(-/-)RB(-/-)) originate leiomyosarcoma after subcutaneous (s.c.) inoculation. Here, we show that intrabone or periosteal inoculation of p53(-/-) or p53(-/-)RB(-/-) bone marrow- or adipose tissue-derived MSCs originated metastatic osteoblastic osteosarcoma (OS). To assess the contribution of bone environment factors to OS development, we analyzed the effect of the osteoinductive factor bone morphogenetic protein-2 (BMP-2) and calcified substrates on p53(-/-)RB(-/-) MSCs. We show that BMP-2 upregulates the expression of osteogenic markers in a WNT signaling-dependent manner. In addition, the s.c. coinfusion of p53(-/-)RB(-/-) MSCs together with BMP-2 resulted in appearance of tumoral osteoid areas. Likewise, when p53(-/-)RB(-/-) MSCs were inoculated embedded in a calcified ceramic scaffold composed of hydroxyapatite and tricalciumphosphate (HA/TCP), tumoral bone formation was observed in the surroundings of the HA/TCP scaffold. Moreover, the addition of BMP-2 to the ceramic/MSC implants further increased the tumoral osteoid matrix. Together, these data indicate that bone microenvironment signals are essential to drive OS development. © AlphaMed Press.

Entities:  

Keywords:  Bone; Bone morphogenetic protein-2; Mesenchymal stem cells; Osteosarcoma; Rb; Tumoral microenvironment; WNT signaling; p53

Mesh:

Substances:

Year:  2014        PMID: 24446210     DOI: 10.1002/stem.1647

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  35 in total

Review 1.  Bone microenvironment signals in osteosarcoma development.

Authors:  Arantzazu Alfranca; Lucia Martinez-Cruzado; Juan Tornin; Ander Abarrategi; Teresa Amaral; Enrique de Alava; Pablo Menendez; Javier Garcia-Castro; Rene Rodriguez
Journal:  Cell Mol Life Sci       Date:  2015-05-03       Impact factor: 9.261

2.  Polydatin Incorporated in Polycaprolactone Nanofibers Improves Osteogenic Differentiation.

Authors:  Stefania Lama; Amalia Luce; Giuseppe Bitti; Pilar Chacon-Millan; Annalisa Itro; Pasquale Ferranti; Giovanni D'Auria; Marcella Cammarota; Giovanni Francesco Nicoletti; Giuseppe Andrea Ferraro; Chiara Schiraldi; Michele Caraglia; Evzen Amler; Paola Stiuso
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-08

3.  The promising role and prognostic value of miR-198 in human diseases.

Authors:  Xiaoping Wang; Yanxia Zhu; Qiuli Xie
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

4.  Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.

Authors:  Adam Nowakowski; Katarzyna Drela; Justyna Rozycka; Miroslaw Janowski; Barbara Lukomska
Journal:  Stem Cells Dev       Date:  2016-09-07       Impact factor: 3.272

Review 5.  Bone morphogenetic protein signaling in musculoskeletal cancer.

Authors:  Myrto Bami; Andreas F Mavrogenis; Andrea Angelini; Mandy Milonaki; Evanthia Mitsiokapa; Dimitrios Stamoulis; Panayotis N Soucacos
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-04       Impact factor: 4.553

6.  Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism.

Authors:  Huensuk Kim; Seungyeul Yoo; Ruoji Zhou; An Xu; Jeffrey M Bernitz; Ye Yuan; Andreia M Gomes; Michael G Daniel; Jie Su; Elizabeth G Demicco; Jun Zhu; Kateri A Moore; Dung-Fang Lee; Ihor R Lemischka; Christoph Schaniel
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-01       Impact factor: 11.205

7.  Prediction of neoadjuvant chemotherapy response in high-grade osteosarcoma: added value of non-tumorous bone radiomics using CT images.

Authors:  Lei Xu; Pengfei Yang; Kun Hu; Yan Wu; Meng Xu-Welliver; Yidong Wan; Chen Luo; Jing Wang; Jinhua Wang; Jiale Qin; Yi Rong; Tianye Niu
Journal:  Quant Imaging Med Surg       Date:  2021-04

8.  Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties.

Authors:  Juan Tornín; Aranzazu Villasante; Xavi Solé-Martí; Maria-Pau Ginebra; Cristina Canal
Journal:  Free Radic Biol Med       Date:  2021-01-02       Impact factor: 7.376

9.  mTORC1 maintains the tumorigenicity of SSEA-4(+) high-grade osteosarcoma.

Authors:  Wu Zhang; Meng-Lei Ding; Jia-Nian Zhang; Jian-Ru Qiu; Yu-Hui Shen; Xiao-Yi Ding; Lian-Fu Deng; Wei-Bin Zhang; Jiang Zhu
Journal:  Sci Rep       Date:  2015-04-08       Impact factor: 4.379

10.  Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.

Authors:  Lucia Martinez-Cruzado; Juan Tornin; Laura Santos; Aida Rodriguez; Javier García-Castro; Francisco Morís; Rene Rodriguez
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.